fbpx
QQQ
+ 0.61
283.19
+ 0.21%
DIA
+ 0.88
281.25
+ 0.31%
SPY
+ 1.17
340.96
+ 0.34%
TLT
-1.53
162.31
-0.95%
GLD
+ 0.84
177.58
+ 0.47%

VerdeMed Expands In Latin America With CBD Treatment, New Exec Team

September 24, 2020 1:58 pm
Share to Linkedin Share to Twitter Share to Facebook Share to Print More

Canadian cannabis startup VerdeMed has been expanding across Latin America.

Over the last few months, the company started selling CBD products to select patients in Brazil, won four public bids to supply local governments with cannabis-derived products, and closed a deal to supply its products to Chile as well.

In its most recent move, VerdeMed developed and launched its first in-house medical cannabis product. Dubbed Sativyl, this product is a generic alternative to GW Pharmaceutical (NASDAQ:GWPH)’s Sativex. Containing both THC and CBD, it is used to treat spasticity, or muscular hypertonia, associated to multiple sclerosis.

“It was because of this product that it all started. We have been developing the formulation in Canada for two years, since the company’s inception,” Jairo Koda, director of operations at VerdeMed, told Brazilian newspaper Folha de S. Paulo.

The company assures Sativyl will cost between 20% and 30% less than Sativex.

Applications for the approval of Sativyl has been filed in Peru and Brazil.

More To Come

CEO Jose Bacellar told Benzinga that VerdeMed is far from done in Latin America. The company plans to register a line of derma-cosmetic products in Colombia; scale-up its Chilean operations with “bulk” shipments; develop an entry strategy for the Mexican market – after new regulatory framework comes into effect; and file another dossier in Brazil for a formulation that’s equivalent to GW Pharmaceuticals’ Epidiolex.

The company has four additional formulations under development in Canada. Bacellar expects them to hit the market in 2021.

In order to implement the business strategy, VerdeMed has brought on senior cannabis executives with prior experience at Canopy Growth Corp (NYSE:CGC) and Khiron Life Sciences Corp. (OTCQX:KHRNF). Luis Chavez M.D. will be joining the company to manage the Mexican market; Oscar Gutierrez will focus on Colombia; and Patrício Aguirre will oversee the market in Chile.

“One cannot aspire to capturing the massive business opportunities emerging from the largest economies in LatAm without solid boots-on-the-ground, experienced leadership teams,” Fabio Lampugnani, Verdemed’s LatAm managing director concluded. “I believe we are building a talented executive leadership at par with VerdeMed’s growth ambitions and plans.”

Don’t miss this opportunity to connect with THE cannabis movers and shakers from across the globe, including VerdeMed, during Benzinga’s third Virtual Cannabis Capital Conference on October 15.

Lead image by Ilona Szentivanyi. Copyright: Benzinga.


Related Articles

Michele Harrington To Lead Education, Fundraising Efforts For CBD Sexual Wellness Brand

Foria, a health and sexual wellness brand, has enlisted Michele Harrington — the wife of Viola founder Al Harrington — as an advisor and head of strategic partnerships. read more

Cable Provider 4Cable To Venture Into CBD Space, Considers Two Acquisitions

4Cable TV International Inc. (PINK: CATV) is looking to acquire two CBD companies. The Port St. Lucie, Florida-based company expects to announce its final decision in the weeks to come. read more

What Are Some Common Side Effects Of CBD Oil?

This article was originally published on Cannabis & Tech Today, and appears here with permission. CBD, one of the main components of the cannabis plant, is now being looked at as a highly effective remedy for all kinds of conditions. read more

Cannabis Proves To Be Popular Among Newlyweds — And Their Pets

Marijuana themes are proving to be popular in two particular areas — pets and weddings. Benzinga spoke with several business operators who say incorporating cannabis into their offerings has only bolstered business. read more

The Week In Cannabis: Aphria Earnings, Canopy's Distribution Deal, And A Big Conference

This was an exciting week for the cannabis industry, marked by the ninth edition of the Benzinga Cannabis Capital Conference. Benzinga’s last big cannabis event of 2020 took place virtually, featuring almost 100 speakers from all around the world. Read some of the key takeaways: read more